The synthetic peptide known as Semax was first created in the 1980s by scientists in Russia. Since its initial synthesis, the peptide has been evaluated in research studies related to Ischemic stroke, encephalopathy, optic nerve atrophy, and cognitive diseases like dementia in Russia and the Ukraine. Researchers have also evaluated the impact of peptide exposure […]
